Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Agriculture
Automobiles
Business
Construction/Realestate
Culture/Entertainment
Education
Energy/Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy/Government
Retail
Society
Sports
Technology
Transportation
Travel
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Agriculture
Automobiles
Business
Construction / Realestate
Culture / Entertainment
Education
Energy / Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy / Government
Retail
Society
Sports
Technology
Transportation
Travel
Health News Releases
Today June 9
August 23, 2022 14:00
Medisca Unveils New Brand Identity and Corporate Positioning as Partners in Wellness
After three successful decades of redefining, shaping, and informing the pharmaceutical compounding industry standard, Medisca is proud to unveil a new global brand identity and corporate positioning
August 23, 2022 11:35
Solasia Announces Launch of Darvias® in Japan
Solasia Pharma K.K. (TOKYO:4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) officially announced today that an organoarsenic drug “DARVIAS® Injection 135mg” (S
August 22, 2022 16:30
VFMCRP announces U.S. Court upholds validity of Velphoro® patent
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the U.S. District Court for the District of Delaware issued a judgment in VFMCRP’s favor regarding U.S. patent no. 9,561,251 whi
August 19, 2022 14:50
Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that they have received approval for Kapruvia® from the Swiss Agency for Therapeutic Produ
August 18, 2022 16:40
Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that England’s National Institute for Health and Care Excellence (NICE) has recommended Tavneos® in combination with a rituxim
August 10, 2022 11:10
Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic
Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) will hold a meeting on September 22
August 05, 2022 11:10
GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution
Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a nov
August 04, 2022 17:25
ImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial
ImmunAbs Inc. (www.immunabs.com) announced that it has received US FDA approval for a Phase 1 clinical trial and that it is now ready to initiate a phase 1 clinical trial in the United States. Immu
August 04, 2022 15:45
First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continued to increase its supply of medicine to patients in the first half of 2022, as it expanded its research pipeline in a
August 04, 2022 14:40
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on related clinical trials and studies of vaccination f
August 03, 2022 11:55
Adalvo Acquires Its First Branded Product, Onsolis®
The global pharmaceutical company Adalvo today announced the acquisition of its first branded product, Onsolis® after concluding a deal with a reputable US based specialty pharmaceutical Company, that
August 03, 2022 11:05
Wilhelm von Haller is Chief Financial Officer of Lysando AG
Lysando AG - market leader in the field of antimicrobial proteins - is pleased to announce that Wilhelm von Haller has joined the team as Chief Financial Officer this March. Baron von Haller is an exp
August 02, 2022 17:05
Finalization of Vifor Pharma acquisition
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Limited (ASX: CSL; USOTC:CSLLY) is pleased to announce it has now received all necessary regulatory clearances for the acquisition
August 02, 2022 11:30
Graminex®, L.L.C. Completes Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence with Positive Results.
Graminex®, L.L.C. is pleased to announce it has completed a clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health with positive results. This study wa
July 29, 2022 14:00
Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Management Guidance
Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the first quarter of fiscal year 2022 (period ended June 30, 2022) and is on track to meet its full-year management guidance.
July 29, 2022 11:20
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate
Organon (NYSE: OGN), a global women’s healthcare company, and Cirqle Biomedical today announced they have entered into a research collaboration and exclusive license agreement for a novel investigatio
July 28, 2022 11:10
PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced a significant expansion of its world-class facility in Tredegar, Wales, UK, desi
July 26, 2022 15:00
EssilorLuxottica Modernizes Order Processing With Boomi’s Intelligent Integration Platform
Boomi™, the intelligent connectivity and automation leader, today announced that EssilorLuxottica, a global leader in the eyewear market, has implemented Boomi's integration platform as a service (iPa
July 25, 2022 16:23
Increased Adoption of Imaging Technology To Detect And Monitor Ailment Severity Is Accelerating The Mobile Imaging Services Industry In Asia Pacific: Scrutinized Report By Fact.MR
The mobile imaging services market is predicted to account for USD 2.7 billion in 2032, up from USD 1.9 billion in 2022, advancing at a CAGR of 3.9% during the forecast period (2022-2032). The incr
July 22, 2022 16:10
Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating HYQVIA® for Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda (TSE:4502/NYSE:TAK) today announced that ADVANCE-1, a randomized, placebo-controlled, double-blind Phase 3 clinical trial evaluating HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombina
July 22, 2022 13:45
Neuraptive Therapeutics Announces First Patient Enrolled in a Phase 2 Trial of NTX-001 for the Prevention of Facial Paralysis and Provides Update on the Phase 2 Study of NTX-001 in Peripheral Nerve Injuries due to Trauma
Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical products for the treatment of peripheral nerve injuries (PNI),
July 22, 2022 09:55
Siemens Korea Digital Industries Holds 9th Smart NC Contest Award Ceremony
Digital Industries (DI) of Siemens Korea (Siemens Ltd. Seoul·SLS) held the 9th Smart Numerical Control (NC) Contest Award Ceremony on July 21 at the Korea Digital Enterprise Experience Center (KDEXc)
July 22, 2022 09:40
DentalMonitoring: July Product Announcements
DentalMonitoring has launched a breakthrough service for dental professionals and industry partners: the DM Intelligent Platform is now the only digital workflow which can interface and integrate with
July 21, 2022 16:20
Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs
February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human GPCR antibodies u
July 21, 2022 14:30
Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery
Masimo (NASDAQ: MASI) today announced the findings of a randomized, controlled trial published in the Journal of Clinical Anesthesia in which Dr. Melody H.Y. Long and colleagues from the KK Women’s an
July 21, 2022 09:40
STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project
REPO4EU consortium seeks to address the urgent need for new cost-effective therapies, as well as to improve existing treatments through international cooperation, pooling research and innovation exper
July 20, 2022 14:00
Prestigous West Coast Academic Medical Center Renews Six-Figure, Multi-Year Agreement For Privacy And Security Managed Services
CynergisTek, Inc. (NYSE American: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issue
July 20, 2022 10:30
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III clinical trial for SINOVAC’s inactivated quadriva
July 20, 2022 09:05
Pharma Proposes to Work with G7 and G20 on a Joint Solution for Better Access to Vaccines and Treatments Around the World for Future Pandemics
The biopharmaceutical industry launched today the “Berlin Declaration - biopharmaceutical industry vision for equitable access in pandemics” and presents global leaders with a proposal that could help
July 19, 2022 19:00
Covac Global Redefines Duty of Care With No Hospitalization Requirement for Repatriation and Newly-added Coverage for Monkeypox
Covac Global, the Premier Medical Evacuation Membership, pioneered the simple approach to medical evacuation with “Get Sick, Get Home” requiring no hospitalization, announces it will include repatriat
July 19, 2022 14:21
Peoplecare Chooses Boomi and Atturra To Connect Member Data For Personalized Health Fund Experiences
Boomi™, the intelligent connectivity and automation leader, today announced that Peoplecare, an Australian health insurance mutual fund, implemented The Boomi AtomSphere™ Platform to deliver improved
July 18, 2022 21:15
Q2 Update by PQE Group: Two Acquisitions’ Announcements With United Pharma Technologies Inc. & Quintian Pharma, and New Two Offices
The first half of 2022 has closed highly positively for PQE Group, the global women-owned quality consulting company for Lifesciences. The Italian parent Group, after having concluded 2021 with + 20%
July 18, 2022 16:11
Growing Prevalence of Bleeding Disorders and Advancements in Treatments to Bolster Market Revenue; Reaching USD 19.9 Bn: Report Fact.MR
As per an in-depth industry analysis on bleeding disorders treatment by Fact.MR, market research and competitive intelligence provider, the global market is anticipated to expand at a CAGR of 6.7% ove
July 15, 2022 11:00
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-19 vaccine (CoronaVac) has been approved by the Bra
July 13, 2022 16:45
Extension of the postponement of the settlement of Vifor Pharma tender offer
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Limited (ASX: CSL; USOTC:CSLLY) today announced an update regarding the Vifor Pharma AG acquisition. On January 18, 2022, CSL B
July 13, 2022 11:30
Fluke Biomedical OneQA Now Supports Patient Monitor Testing
Fluke Biomedical announced the OneQA test and workflow automation software now supports the top-selling ProSim 8 multifunction patient simulator. Fluke Biomedical OneQA is an industry-leading quality
July 13, 2022 10:10
Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim
The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record
July 12, 2022 10:15
Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock Exchange
Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) today announced that it has filed its Corporate Governance Report with the Tokyo Stock Exchange (“TSE”) in accordance with the re
July 12, 2022 09:24
Why Oral Care is Receiving the Most Support Among Different Types of Dental Laboratories; Sales To Top With USD 5.3 Bn by 2032: Latest Study by Fact.MR
The dental laboratories market revenues were estimated at USD 29.6 Bn in 2021 and are anticipated to grow at a CAGR of 5.6% from 2022-2032, according to a recently published Fact.MR report. By the
July 08, 2022 14:10
New Study shows Urolithin A (Mitopure®) Improves Mitochondrial Health, Reduces Joint Cartilage Damage and Alleviates Pain in Osteoarthritis
Amazentis, a spin-off of the Swiss Federal Institute of Technology (EPFL) pioneering scientific breakthroughs in cellular health and nutrition, announced today that the peer-reviewed journal Aging Cel
July 07, 2022 10:10
KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland
KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, held a joint ribbon-cutting ceremony yesterday at their new state-of-the-art facility in Geneva, Switzerland. Designed to direc
July 07, 2022 09:20
Growing Applications In Clinical Research Activities Have Significant Importance In Developments Of Healthcare Automation Market With Anticipation Of USD 88.9 Bn: Fact.MR
Fact.MR, a market research and competitive intelligence provider, has conducted a comprehensive analysis of the healthcare automation market, which is expected to rise at a CAGR of 8.4% over the forec
July 06, 2022 16:15
Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, the life science company Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and bioMérie
July 06, 2022 13:20
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
The collaboration combines Aurigene’s small molecule drug discovery platform and EQRx's pioneering business model to accelerate the development of drug candidates in the areas of oncology and immune-i
July 05, 2022 13:25
Vetter’s Newest Clinical Manufacturing Site Successfully Completed its First Customer Fills
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manu
July 05, 2022 11:40
SINOVAC joins hands with HKU-CTC research team and Gleneagles Hospital Hong Kong to kick off a clinical trial of an Omicron-specific inactivated vaccine for booster use in Hong Kong, China
A kick off ceremony was held at Gleneagles Hospital Hong Kong (Gleneagles or GHK) for initiating a clinical trial to assess the safety and immunogenicity of the SINOVAC’s Omicron-specific COVID-19 ina
July 01, 2022 15:19
Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years
Takeda (TSE:4502/NYSE:TAK) today announced late-breaking data from the Phase 3 SPRING study (NCT04070326) presented at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2
July 01, 2022 13:45
Spinal Cord Stimulation Delivers Improved Arm Function
ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces a Na
July 01, 2022 10:00
Medidata Announces Rapid Expansion of its Sensor Cloud Network with the Addition of 10 Health Technology Innovators
Medidata, a Dassault Systèmes company, announced 10 highly innovative organizations have joined its groundbreaking Sensor Cloud Network. AliveCor, Aural Analytics, Biobeat, Blue Spark Technologies, Gl
June 30, 2022 10:55
MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis
MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced today that they have received regulatory approval from the Federal A
«
5
6
7
8
9
»
50 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
74,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 162 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Agriculture
Automobiles
Business
Construction / Realestate
Culture / Entertainment
Education
Energy / Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy / Government
Retail
Society
Sports
Technology
Transportation
Travel
Notice